MEASUREMENT OF VASCULAR VOLUME FRACTION AND BLOOD-TISSUE PERMEABILITY CONSTANTS WITH A PHARMACOKINETIC MODEL - STUDIES IN RAT MUSCLE TUMORS WITH DYNAMIC GD-DTPA ENHANCED MRI

We propose a compartmental model to explain the signal enhancement curves following the bolus injection of GdDTPA. The model incorporates vascular volume fraction contribution, and the possibility of having different transport constants between the plasma and extravascular components. A Walker 256 carcinoma grown in rat muscle was used to demonstrate the capability of this model. Several different types of tissues were included in the measurements: normal, quickly enhanced, slowly enhanced, and necrotic tissues. Blood volume and blood-tissue permeability information can be derived from the dynamic contrast-enhanced MRI study employing the proposed model. In the tissue contrast enhancement curve, the initial rising slope after injection is related to the blood volume (or, vascular volume fraction), the maximum enhancement ratio is related to the uptake of tissue, and the decay rate is related to the clearance of tracer from tissue. The measured permeability constant is not the conventional permeability; instead they are contrast agents uptake and clearance rates, which are limited by the blood perfusion. These parameters can be used to characterize different enhancement patterns.